FDA approves Amgen's treatment for most deadly form of lung cancer
Publishing timestamp: 2024-05-16 17:47:17
Summary
The FDA approved Amgen's treatment for patients with the most deadly form of lung cancer, showing promising results in reducing tumor growth and extending the lives of patients. The drug, called Imdelltra, will be available as a second or later-line treatment for advanced small-cell lung cancer. Patients in clinical trials have seen significant improvements, with some experiencing tumor shrinkage and longer survival times.
Sentiment: POSITIVE
Keywords: business, health care industry, breaking news, science, biotech and pharmaceuticals, amgen inc, pharmaceuticals, business news, biotechnology,
Source: https://www.cnbc.com/2024/05/16/fda-approves-amgen-small-cell-lung-cancer-treatment.html